pd 98059 has been researched along with Stasis Ulcer in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Excerpt | Relevance | Reference |
|---|---|---|
| " All experimental conditions were determined by dose-response and time-course experiments." | 1.35 | Regulation of matrix contraction in chronic venous disease. ( Durán, WN; Lal, BK; Ohara, N; Pappas, PJ; Saito, S; Zapiach, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pappas, PJ | 1 |
| Lal, BK | 1 |
| Ohara, N | 1 |
| Saito, S | 1 |
| Zapiach, L | 1 |
| Durán, WN | 1 |
1 other study available for pd 98059 and Stasis Ulcer
| Article | Year |
|---|---|
Regulation of matrix contraction in chronic venous disease.
Topics: Actins; Case-Control Studies; Cells, Cultured; Chronic Disease; Collagen; Dose-Response Relationship | 2009 |